CATALOGO DEI PRODOTTI DELLA RICERCA

FERRARINI, Isacco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.337
EU - Europa 2.785
AS - Asia 1.994
SA - Sud America 274
Continente sconosciuto - Info sul continente non disponibili 101
AF - Africa 100
OC - Oceania 21
Totale 8.612
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.237
RU - Federazione Russa 1.200
SG - Singapore 769
IT - Italia 538
CN - Cina 416
GB - Regno Unito 258
VN - Vietnam 233
DE - Germania 222
BR - Brasile 194
HK - Hong Kong 175
BD - Bangladesh 158
FR - Francia 104
FI - Finlandia 103
SE - Svezia 91
IE - Irlanda 89
CA - Canada 55
KR - Corea 53
IN - India 44
NL - Olanda 41
ID - Indonesia 37
PL - Polonia 29
ES - Italia 27
AR - Argentina 25
MX - Messico 24
AT - Austria 22
NG - Nigeria 21
AU - Australia 20
BJ - Benin 19
EC - Ecuador 19
TR - Turchia 19
ZA - Sudafrica 19
JP - Giappone 18
UA - Ucraina 13
IQ - Iraq 12
TG - Togo 10
CL - Cile 9
SA - Arabia Saudita 8
BE - Belgio 7
CO - Colombia 7
CZ - Repubblica Ceca 7
MA - Marocco 7
PT - Portogallo 7
SC - Seychelles 7
IR - Iran 6
DK - Danimarca 5
JM - Giamaica 5
PE - Perù 5
PK - Pakistan 5
PY - Paraguay 5
TN - Tunisia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
LT - Lituania 4
NP - Nepal 4
PH - Filippine 4
BO - Bolivia 3
CH - Svizzera 3
HN - Honduras 3
IL - Israele 3
KG - Kirghizistan 3
NI - Nicaragua 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
CG - Congo 2
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
MT - Malta 2
MY - Malesia 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
EE - Estonia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
KZ - Kazakistan 1
LB - Libano 1
LS - Lesotho 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MU - Mauritius 1
MV - Maldive 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
Totale 8.512
Salva come PNG Salva come JPEG
Città #
Dallas 465
Ashburn 437
San Jose 436
Moscow 432
Singapore 426
Hong Kong 172
Chandler 165
Verona 162
Council Bluffs 142
Southend 133
Munich 121
Beijing 112
New York 108
Dublin 82
Los Angeles 79
Ho Chi Minh City 76
Helsinki 69
The Dalles 60
Santa Clara 57
Milan 48
Hanoi 46
Jacksonville 45
Buffalo 37
London 33
Princeton 29
Rome 29
Lawrence 28
Houston 26
São Paulo 26
Warsaw 26
Woodbridge 26
Jakarta 25
Orem 25
Columbus 23
Phoenix 22
Chicago 21
Jinan 20
Bologna 19
Cotonou 19
Tianjin 19
Wilmington 19
Seattle 18
Brooklyn 17
Toronto 17
Ann Arbor 16
Denver 16
Frankfurt am Main 16
Nanjing 16
Redondo Beach 16
Redmond 15
Abuja 14
Tokyo 14
Amsterdam 13
Chennai 13
Lappeenranta 13
McKinney 13
Melbourne 13
Shenyang 13
Sindelfingen 13
Montreal 12
Vienna 12
Zhengzhou 12
Falkenstein 11
Haiphong 11
Stockholm 11
Turku 11
Changsha 10
Johannesburg 10
Lomé 10
Nuremberg 10
San Francisco 10
Stuttgart 10
Ankara 9
Belfast 9
Dong Ket 9
Fairfield 9
Manchester 9
Seoul 9
Washington 9
Atlanta 8
Charlotte 8
Cleveland 8
Guangzhou 8
Hebei 8
Newark 8
Rio de Janeiro 8
Vancouver 8
Vicenza 8
Annandale 7
Biên Hòa 7
Boston 7
Florence 7
Guayaquil 7
Hangzhou 7
Lagos 7
Padua 7
Trento 7
Venice 7
Brussels 6
City of London 6
Totale 4.968
Salva come PNG Salva come JPEG
Nome #
T CELL/HISTIOCYTE-RICH LARGE B-CELL LYMPHOMA: CLINICO-PATHOLOGICAL FEATURES AND RESPONSE TO IMMUNE CHECKPOINT INHIBITORS 390
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 242
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 230
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 225
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 225
CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin 218
Synthetic PGI-2 (Iloprost) treatment in patients with resistant sclerodermic chronic GVHD (cGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation 203
CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase 200
BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomes 199
Activation of Protein Tyrosine Phosphatase Receptor Type γ Suppresses Mechanisms of Adhesion and Survival in Chronic Lymphocytic Leukemia Cells 198
A single amino acid substitution in CXCL12 confers functional selectivity at the beta-arrestin level 190
Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent 183
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis 183
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study 182
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study 173
Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter's syndrome 171
Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis 170
Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice 170
Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment 165
COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review 164
Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40 162
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia 160
Monocyte-to-macrophage switch reversibly impaired by Ibrutinib. 159
Pembrolizumab as salvage treatment for T-cell/histiocyte-rich and Epstein-Barr virus-positive large B-cell lymphoma 157
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study 155
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 146
Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report 140
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. 138
IMMUNE THROMBOCYTOPENIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: CASE REPORT AND BRIEF OVERVIEW OF TREATMENT STRATEGIES 136
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 132
An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma 128
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 128
CATALASE BLOCKING INDUCES APOPTOSIS AND POTENTIATES VENETOCLAX-INDUCED CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 127
West Nile Virus Encephalitis in Haematological Setting: Report of Two Cases and a Brief Review of the Literature 124
CAT RS1001179 SINGLE NUCLEOTIDE POLYMORPHISM IDENTIFIES AN AGGRESSIVE CLINICAL BEHAVIOR IN CHRONIC LYMPHOCYTIC LEUKEMIA 122
Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy 122
ONC212 IS A NOVEL MITOCAN ACTING SYNERGISTICALLY WITH GLYCOLYSIS INHIBITION IN PANCREATIC CANCER 118
High prevalence of antibodies reacting to mimotopes of Simian virus 40 large T antigen, the oncoprotein, in serum samples of patients affected by non-Hodgkin lymphoma 116
The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicine 115
Extracellular Vesicles based STAT3 delivery as innovative therapeutic approach to restore STAT3 signaling deficiency 114
A brisk peripheral T-cell reaction following rituximab treatment for follicular lymphoma 102
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort 99
PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF THE B-CELL RECEPTOR SIGNALING IN MANTLE CELL LYMPHOMA 99
BCR signaling activity stratifies patents with MCL with divergent clinical outcome 97
B-CELL RECEPTOR SIGNALING ACTIVITY IDENTIFIES PATIENTS WITH MANTLE CELL LYMPHOMA AT HIGHER RISK OF PROGRESSION 96
The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment 94
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey 93
ACTIVATION OF BCR SIGNALING REWIRES THE RESPONSE OF BCR-ASSOCIATED KINASES TO IBRUTINIB IN MANTLE CELL LYMPHOMA CELLS 92
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 90
ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer 85
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia 83
Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax Transition in Relapsed Chronic Lymphocytic Leukemia Patients 83
The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population 81
Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia 78
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma 78
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper 77
Outcomes of younger patients with mantle‐cell lymphoma experiencing late relapse (>24 months): the LATE‐POD study 74
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 72
THE PROGNOSTIC SIGNIFICANCE OF MYC AND BCL2 PROTEIN DOUBLE EXPRESSION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, NOS, IN THE ABSENCE OF MYC REARRANGEMENT 65
Zanubrutinib in Hairy Cell Leukemia Variant: Clinical Report and Overview of BTK Inhibition in Variant Disease 45
Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy 29
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study 22
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d positive CLL mainly expressed in trisomy 12 18
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study 18
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort 15
Serositis as possible manifestation in MDS/AML patients with complex karyotype and TP53 mutation: case series 15
Genes-first and phenotypes-first paths to treatment resistance in hematological malignancies 11
Rethinking the feasibility and safety of venetoclaxobinutuzumab in chronic lymphocytic leukemia: nontraditional factors may play a role in clinical practice 11
Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study 10
Totale 8.612
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.385
article - articoli 26.472
book - libri 0
conference - conferenze 2.253
curatela - curatele 0
other - altro 660
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022155 0 0 0 10 35 4 7 12 4 14 12 57
2022/2023500 30 67 37 92 38 112 11 36 57 6 7 7
2023/2024327 11 30 49 34 25 41 20 26 9 20 49 13
2024/20251.268 46 49 72 180 55 84 84 86 184 83 124 221
2025/20264.966 216 393 290 632 1.302 279 377 276 377 236 243 345
2026/2027824 113 205 242 264 0 0 0 0 0 0 0 0
Totale 8.612